APOC1 antibody (Internal Region)
-
- Target See all APOC1 Antibodies
- APOC1 (Apolipoprotein C-I (APOC1))
-
Binding Specificity
- Internal Region
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This APOC1 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)
- Specificity
- APOC1 Antibody detects endogenous levels of total APOC1.
- Predicted Reactivity
- Rabbit,Dog
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human APOC1, corresponding to a region within the internal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product APOC1 Primary Antibody
-
-
- Application Notes
- WB 1:1000-3000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C. Stable for 12 months from date of receipt.
- Expiry Date
- 12 months
-
- Target
- APOC1 (Apolipoprotein C-I (APOC1))
- Alternative Name
- APOC1 (APOC1 Products)
- Synonyms
- Apo-CIB antibody, ApoC-IB antibody, ALPCI antibody, LRRG04 antibody, APOC1 antibody, apoc1 antibody, apolipoprotein C1 antibody, apolipoprotein C-I antibody, Apolipoprotein C-I antibody, APOC1 antibody, Apoc1 antibody, apoc1 antibody
- Background
-
Description: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.
Gene: APOC1
- Molecular Weight
- 9 kDa
- Gene ID
- 341
- UniProt
- P02654
- Pathways
- Apoptosis
-